We have been attaching importance on R & D, transfer and industrial application of scientific and technological achievements, have made sustained, rapid and sound development of productive force. 牋牋
牋牋
The Technical Center of our company, on the base of the increasing science & technology investment and technical personnel training, develops mainly the new technologies and the new products of intermediates serial of steroid hormone drugs. The self-developed new technologies of diogenin, 16-DPA, 16?17?epoxy progesterone, 17?hydroxy progesterone acetate were appraised to reach the leading level in domestic same industry by Provincial Science and Technology Department. Our 16-DPA and 17?hydroxy progesterone acetate were appraised as National Key New Product. The application of new research achievements has improved the core competitiveness and economic efficiency rapidly. We utilize the self-produced 16-DPA of high quality as the raw material, have developed and produced the over 10 sorts of intermediates of steroid hormone drugs such as 16?17?epoxy progesterone, 17?hydroxy progesterone, 17?hydroxy progesterone acetate, etc, and are developing the serial intermediates of steroid hormone drugs such as 11?hydroxy -16?17?epoxy progesterone, etc. Because we have established two holding companies whose annual capacity is 100 tons of diosgenin at Gucheng county and at Yunxi county respectively in raw material base, we have strongly supporting of raw materials, our company has the advantage of that it is only enterprise which has raw material processing base in the same industry. Fangtong and the partner of the same industry together built Xinyi Pharmceutical & Chemical Co., Ltd. specialized in manufacturing advanced intermediates of steroid hormone drugs, we expand the area of further processing together by the way of uniting. The stable raw material resource and the optimization for the distribution of resources and techniques establishes the solid base on which we devote to downstream processing of production, and expand the domestic and foreign markets further, realize the sustainable development on the way to the specialization of the intermediates of steroid hormone drugs. |
|
|
